⌕
Collegium Pharmaceutical · COLL · Nasdaq
Tenet 60 · Solid
Compare
$25.55+0.47%At closeTenet 60 · Solid
$25.55+0.12 (+0.47%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Collegium Pharmaceutical (COLL) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Sep 30, 2026: more funds trimmed or exited than added or entered, mild distribution (37 new · 85 increased · 91 reduced · 74 closed). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 239 filers, Sep 30, 2026
# 13F FUNDS
239
13F VALUE
$803.1M
36.8M shares
Withheld: the 13F filers report more shares than the company has outstanding, which happens when shared or lent shares are counted twice. The filer count, shares and value are as filed.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Jun 8, 2026SANTINI GINOdirectorAcquired · Option exercise8,700$16.49↗
Jun 8, 2026SANTINI GINOdirectorDisposed · Option exercise8,700Stock Option (Right to Purchase)—↗
May 18, 2026Freund John GordondirectorDisposed · Open-market sale20$34.05↗
May 15, 2026Freund John GordondirectorAcquired · Option exercise8,700$16.49↗
May 15, 2026Freund John GordondirectorDisposed · Open-market sale4,127$34.54↗
May 15, 2026Freund John GordondirectorDisposed · Option exercise8,700Stock Option (Right to Purchase)—↗
May 14, 2026Glancy Donovan MichaeldirectorAcquired · Grant / award17,482—↗
May 14, 2026Balice-Gordon Rita J.directorAcquired · Grant / award8,741—↗
May 14, 2026Paya Carlos VdirectorAcquired · Grant / award8,741—↗
May 14, 2026Lurker NancydirectorAcquired · Grant / award8,741—↗
May 14, 2026Freund John GordondirectorAcquired · Grant / award8,741—↗
May 14, 2026SANTINI GINOdirectorAcquired · Grant / award8,741—↗
May 14, 2026BOHLIN GAREN GdirectorAcquired · Grant / award8,741—↗
May 13, 2026Lurker NancydirectorDisposed · Open-market sale4,500$35.97↗
May 11, 2026BOHLIN GAREN GdirectorAcquired · Option exercise8,700$16.49↗
May 11, 2026BOHLIN GAREN GdirectorDisposed · Open-market sale8,700$37.18↗
May 11, 2026BOHLIN GAREN GdirectorDisposed · Option exercise8,700Stock Option (Right to Purchase)—↗
Mar 18, 2026Dieter DavidEVP & General CounselDisposed · Open-market sale13,976$34.92↗
Mar 17, 2026Dieter DavidEVP & General CounselDisposed · Tax withholding8,840$35.72↗
Mar 9, 2026Dieter DavidEVP & General CounselDisposed · Open-market sale6,224$36.65↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold Collegium Pharmaceutical?

Collegium Pharmaceutical was held by 239 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.